The Arab Republic of Egypt sent hepatitis C medicines to Uzbekistan for the first time

On September 9 of this year, an event dedicated to the administration of drugs against the hepatitis C virus was held at the Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases - gratuitous aid from the Arab Republic of Egypt to Uzbekistan.

The event was attended by the Head of the Department for Coordination of Specialized Centers of the Ministry of Health Zainiddin Asamutdinovich Saifutdinov, Deputy Head of the Service for Sanitary and Epidemiological Welfare and Public Health  Kurbanov Botirjon Zhurabaevich, Director of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases Tadjiev Botir Mirkhashimovich, Ambassador Extraordinary and Plenipotentiary of the Arab Republic of Egypt to Uzbekistan Ms. Amira Fahmi, Head of the Department of the Middle East and Africa of the Ministry of Foreign Affairs Ismatilla Fayzullaev, Director of the Research Institute of Virology of the Republican Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases, and representatives of the media.

According to the World Health Organization (WHO), the hepatitis C virus is annually 200 million people are infected. Thus, according to 2020 data, more than 350,000 patients die annually from complications of hepatitis C. Last year, the World Hepatitis Alliance announced that 1.4 million people die every year from hepatitis B and C viruses. And this means more than from HIV / AIDS and malaria.

The Presidential Resolution of May 16, 2022 "On improving measures to combat the spread of certain viral infections" defines the main areas for further improvement and expansion of medical and social assistance provided to the population for the period timely prevention and diagnosis of certain viral infections among the population, as well as their treatment.

— conducting screening examinations in all regions of the republic for the early detection of viral hepatitis "B" and "C" types and increasing the coverage of disease treatment;

— free provision of drugs during the treatment of patients whose screening tests revealed viral hepatitis type “C”;

— phased full provision of consumables (reagents and test systems) for the detection of viral infections at the primary level of the healthcare system;

— creation and maintenance of a single electronic register of chronic viral liver diseases in all medical and preventive institutions, the sanitary and epidemiological service and non-governmental medical organizations;

In our republic, in cooperation with the Ministry of Health of the Republic of Uzbekistan, the sanitary and epidemiological service and health care of the Republic of Uzbekistan, the processes of free examination in family clinics continue.

In total, the Egyptian government sent 15,000 units of “Sofosbuvir” to our country as gratuitous aid. and 15,000 units of Daclatasvir for a total of $302,000. The drugs are used to treat patients diagnosed with viral hepatitis Type C in screening trials.

At the end of the event, media representatives received answers to their questions.